Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Drug-induced granulomatosis: is dupilumab the new kid on the block?

Belhomme N, Gaignon T, Jouneau S, Misery L, Abasq-Thomas C, Cador B, Lecureur V, Cadiou S, Ballerie A, Polard E, Mensi S, Jego P, Lescoat A.

J Eur Acad Dermatol Venereol. 2020 Jan 20. doi: 10.1111/jdv.16218. [Epub ahead of print] No abstract available.

PMID:
31958359
2.

[Multidisciplinary meetings determining the imputability of xenobiotics in causes of death: What contribution to pharmacovigilance data?]

Lalanne S, Caradec Q, Baert A, Bouvet R, Morel I, Polard E, Gicquel T.

Therapie. 2019 Dec 23. pii: S0040-5957(19)30191-X. doi: 10.1016/j.therap.2019.10.005. [Epub ahead of print] French.

PMID:
31926667
3.

Trends in sodium valproate prescriptions among children aged 0 to 14 years between 2010 and 2016: A study based on the French National Health Insurance Database.

Polard E, Degremont A, Rault C, Le Nautout B, Oger E, Biraben A, Nowak E.

Seizure. 2019 Aug;70:71-76. doi: 10.1016/j.seizure.2019.07.007. Epub 2019 Jul 8.

4.

Moxifloxacin-rifampicin combination for the treatment of non-staphylococcal Gram-positive orthopedic implant-related infections.

Fily F, Jolivet-Gougeon A, Polard E, Gicquel T, Dupont M, Verdier MC, Arvieux C.

Med Mal Infect. 2019 Oct;49(7):540-544. doi: 10.1016/j.medmal.2019.06.008. Epub 2019 Jul 3.

PMID:
31277834
5.

Hepatotoxicity risk factors and acetaminophen dose adjustment, do prescribers give this issue adequate consideration? A French university hospital study.

Bacle A, Pronier C, Gilardi H, Polard E, Potin S, Scailteux LM.

Eur J Clin Pharmacol. 2019 Aug;75(8):1143-1151. doi: 10.1007/s00228-019-02674-5. Epub 2019 Apr 10.

6.

Mining clinical big data for drug safety: Detecting inadequate treatment with a DNA sequence alignment algorithm.

Ledieu T, Bouzille G, Plaisant C, Thiessard F, Polard E, Cuggia M.

AMIA Annu Symp Proc. 2018 Dec 5;2018:1368-1376. eCollection 2018.

7.

Timeline representation of clinical data: usability and added value for pharmacovigilance.

Ledieu T, Bouzillé G, Thiessard F, Berquet K, Van Hille P, Renault E, Polard E, Cuggia M.

BMC Med Inform Decis Mak. 2018 Oct 19;18(1):86. doi: 10.1186/s12911-018-0667-x.

8.

Clinical Data Analytics With Time-Related Graphical User Interfaces: Application to Pharmacovigilance.

Ledieu T, Bouzillé G, Polard E, Plaisant C, Thiessard F, Cuggia M.

Front Pharmacol. 2018 Aug 30;9:717. doi: 10.3389/fphar.2018.00717. eCollection 2018.

9.

Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review.

Lavergne A, Vigneau C, Polard E, Triquet L, Rioux-Leclercq N, Tattevin P, Golbin L.

Int J Antimicrob Agents. 2018 Sep;52(3):344-349. doi: 10.1016/j.ijantimicag.2018.04.007. Epub 2018 Apr 14. Review.

10.

Drug safety and big clinical data: Detection of drug-induced anaphylactic shock events.

Bouzillé G, Osmont MN, Triquet L, Grabar N, Rochefort-Morel C, Chazard E, Polard E, Cuggia M.

J Eval Clin Pract. 2018 Jun;24(3):536-544. doi: 10.1111/jep.12908. Epub 2018 Mar 13.

PMID:
29532572
11.

Pulmonary arterial hypertension in four patients treated by leflunomide.

Coirier V, Lescoat A, Chabanne C, Fournet M, Coiffier G, Jouneau S, Polard E, Jégo P.

Joint Bone Spine. 2018 Dec;85(6):761-763. doi: 10.1016/j.jbspin.2017.12.014. Epub 2018 Jan 9.

12.
13.

[Aspirin: Indications and use during pregnancy].

Belhomme N, Doudnikoff C, Polard E, Henriot B, Isly H, Jego P.

Rev Med Interne. 2017 Dec;38(12):825-832. doi: 10.1016/j.revmed.2017.10.419. Epub 2017 Nov 10. Review. French.

PMID:
29129461
14.

Pirfenidone photosensitization in patients with idiopathic pulmonary fibrosis: a case series.

Droitcourt C, Adamski H, Polat A, Polard E, Kerjouan M, Arnouat B, Le Garrec M, Oger E, Dupuy A, Jouneau S.

Br J Dermatol. 2018 Mar;178(3):e222-e223. doi: 10.1111/bjd.16016. Epub 2018 Jan 30. No abstract available.

15.

Acute eosinophilic pneumonia following artenimol-piperaquine exposure.

Fourmont L, Revest M, Polard E, Lederlin M, Delaval P, Desrues B, Tattevin P, Jouneau S.

J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax023.

PMID:
28499010
16.

Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance data.

Scailteux LM, Vincendeau S, Balusson F, Leclercq C, Happe A, Le Nautout B, Polard E, Nowak E, Oger E.

Eur J Cancer. 2017 May;77:99-108. doi: 10.1016/j.ejca.2017.03.002. Epub 2017 Apr 5.

PMID:
28390298
17.

Manic switches induced by antidepressants: an umbrella review comparing randomized controlled trials and observational studies.

Allain N, Leven C, Falissard B, Allain JS, Batail JM, Polard E, Montastruc F, Drapier D, Naudet F.

Acta Psychiatr Scand. 2017 Feb;135(2):106-116. doi: 10.1111/acps.12672. Epub 2016 Nov 23. Review.

18.

[Peranesthesic Anaphylactic Shocks: Contribution of a Clinical Data Warehouse].

Osmont MN, Campillo-Gimenez B, Metayer L, Jantzem H, Rochefort-Morel C, Cuggia M, Polard E.

Therapie. 2015 Oct 16. [Epub ahead of print] French.

PMID:
26475750
19.

Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.

Polard E, Nowak E, Happe A, Biraben A, Oger E; GENEPI Study Group.

Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1161-9. doi: 10.1002/pds.3879. Epub 2015 Sep 23.

20.

[Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years].

Picard S, Polard E, Oger E, Bellissant E.

Therapie. 2015 May-Jun;70(3):293-9. doi: 10.2515/therapie/2014216. Epub 2014 Dec 24. French.

PMID:
25534522
21.

[Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review].

Scailteux LM, Guedes C, Polard E, Perdriger A.

Presse Med. 2015 Jan;44(1):4-10. doi: 10.1016/j.lpm.2014.06.028. Epub 2014 Dec 19. Review. French.

PMID:
25534463
22.

Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients.

Chabbert C, Adamski H, Guillet G, Sassolas B, Misery L, Perrinaud A, Machet L, Quereux G, Esteve E, Solau-Gervais E, Saraux A, Polard E, Lesimple T, Le Gall F, Dreno B, Dupuy A.

J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1540-4. doi: 10.1111/jdv.12347. Epub 2013 Dec 13.

PMID:
24329560
23.

[Use of the PMSI for the detection of adverse drug reactions].

Osmont MN, Cuggia M, Polard E, Riou C, Balusson F, Oger E.

Therapie. 2013 Jul-Aug;68(4):285-95. doi: 10.2515/therapie/2013042. Epub 2013 Aug 28. French.

PMID:
23981266
24.

Enoxaparin-Induced DRESS Syndrome.

Ronceray S, Dinulescu M, Le Gall F, Polard E, Dupuy A, Adamski H.

Case Rep Dermatol. 2012 Sep;4(3):233-7. doi: 10.1159/000345096. Epub 2012 Oct 26.

25.

Complicated atazanavir-associated cholelithiasis: a report of 14 cases.

Rakotondravelo S, Poinsignon Y, Borsa-Lebas F, de la Blanchardière A, Michau C, Jantzem H, Massy N, Polard E, Giroux F, Kerspern H, Meskar A, Hue G, Tribut O, Arvieux C, Tattevin P.

Clin Infect Dis. 2012 Nov;55(9):1270-2. doi: 10.1093/cid/cis620. Epub 2012 Jul 19.

PMID:
22820540
26.

Meta-analysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach.

Oger E, Lavenu A, Bellissant E, Garin E, Polard E.

Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):956-63. doi: 10.1002/pds.2177. Epub 2011 Jul 11.

PMID:
21748824
27.

Photodistributed eruption with rhabdomyolisis due to leflunomide.

Adamski H, Lopez L, Polard E, Chevrant-Breton J, Dupuy A.

Photodermatol Photoimmunol Photomed. 2011 Aug;27(4):222-3. doi: 10.1111/j.1600-0781.2011.00590.x. No abstract available.

PMID:
21729173
28.

[Aripiprazole use in children and adolescent psychiatric patients].

Chevreuil C, Polard E, Lemonnier E, Guillemot P, Bentué-Ferrer D; Groupe d'Etude Interdisciplinaire de Bretagne << Psychotropes chez l'Enfant et l'Adolescent >>.

Therapie. 2011 Mar-Apr;66(2):123-30. Epub 2011 Jun 6. Review. French.

PMID:
21635859
29.

Prescription de l'aripiprazole chez l'enfant et l'adolescent.

Chevreuil C, Polard E, Lemonnier E, Guillemot P, Bentué-Ferrer D.

Therapie. 2011 Mar-Apr;66(2):123-30. doi: 10.2515/therapie/2011012. French.

PMID:
27393647
30.

¹³¹I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases.

Jouneau S, Vauléon E, Caulet-Maugendre S, Polard E, Volatron AC, Meunier C, Tattevin P, Montani D, Garin E, Raoul JL, Delaval P.

Chest. 2011 Jun;139(6):1463-1469. doi: 10.1378/chest.10-1591. Epub 2010 Oct 14.

PMID:
20947651
31.

[Pharmacologic treatment of insomnia in children and adolescent psychiatric patients].

Chevreuil C, Polard E, Gicquel G, Frémaux T, Bentué-Ferrer D; Groupe d'Etude Interdisiplinaire de Bretagne Psychotropes chez l'enfant et l'adolescent.

Therapie. 2010 Jan-Feb;65(1):1-12. doi: 10.2515/therapie/2010001. Epub 2010 Mar 8. Review. French.

PMID:
20205989
32.

3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.

Flet L, Polard E, Guillard O, Leray E, Allain H, Javaudin L, Edan G.

J Neurol. 2010 Jun;257(6):937-46. doi: 10.1007/s00415-009-5442-6. Epub 2010 Jan 8.

PMID:
20058019
33.

Le traitement pharmacologique de l'insomnie en pédopsychiatrie.

Chevreuil C, Polard E, Gicquel G, Frémaux T, Bentué-Ferrer D; pour le Groupe d’Étude Interdisciplinaire de Bretagne « Psychotropes chez l’enfant et l’adolescent».

Therapie. 2010 Jan-Feb;65(1):1-12. doi: 10.2515/therapie/2010001. French.

PMID:
27392916
34.

Short report: Incidence of yellow fever vaccine-associated neurotropic disease.

Guimard T, Minjolle S, Polard E, Fily F, Zeller H, Michelet C, Tattevin P.

Am J Trop Med Hyg. 2009 Dec;81(6):1141-3. doi: 10.4269/ajtmh.2009.09-0295.

PMID:
19996449
35.

[Risperidone use in child and adolescent psychiatric patients].

Chevreuil C, Reymann JM, Frémaux T, Polard E, Séveno T, Bentué-Ferrer D.

Therapie. 2008 Sep-Oct;63(5):359-75. doi: 10.2515/therapie:2008059. Epub 2009 Jan 21. French.

PMID:
19154706
36.

Reversible ageusia as an adverse effect of hydroxychloroquine treatment.

Fleury O, Droitcourt C, Polard E, Chevrant-Breton J.

J Eur Acad Dermatol Venereol. 2009 May;23(5):604-5. doi: 10.1111/j.1468-3083.2008.02984.x. Epub 2008 Aug 21. No abstract available.

PMID:
18721220
37.

[Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept].

Lahbabi I, Adamski H, Le Jean S, Cannieux V, Polard E, Chevrant-Breton J.

Ann Dermatol Venereol. 2008 May;135(5):409-10. doi: 10.1016/j.annder.2008.01.011. Epub 2008 Apr 14. French. No abstract available.

PMID:
18457732
38.

Aseptic meningitis associated with lamotrigine: report of two cases.

Nesseler N, Polard E, Arvieux C, Coquerel N, Michelet C, Tattevin P.

Eur J Neurol. 2007 Dec;14(12):e3-4. No abstract available.

PMID:
18028184
39.

[Disulone and hepatosiderosis].

Darrieux L, Adamski H, Turlin B, Ollivier I, Polard E, Deugnier Y, Chevrant-Breton J.

Ann Dermatol Venereol. 2006 Aug-Sep;133(8-9 Pt 1):683-5. French.

PMID:
17053738
40.

Retransplantation for acute liver failure due to combined antiviral agents in an HIV-HCV coinfected liver transplant recipient.

Polard E, Camus C, Abault AY, Turlin B, Arvieux C, Messner M, Allain H, Boudjema K.

Transplantation. 2005 Oct 27;80(8):1136-8. No abstract available.

PMID:
16278602
41.

Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.

Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A.

Drugs Aging. 2005;22(9):749-65. Review.

PMID:
16156679
42.

Can colchicine potentiate the anticoagulant effect of fluindione?

Gras-Champel V, Ohlmann P, Polard E, Wiesel ML, Imbs JL, Andréjak M.

Eur J Clin Pharmacol. 2005 Aug;61(7):555-6. Epub 2005 Jul 9. No abstract available.

PMID:
16007421
43.

[Mechanisms of chronic cough pathophysiology].

Allain H, Bentue-Ferrer D, Daval G, Polard E, Delaval P, Lagente V.

Rev Mal Respir. 2004 Sep;21(4 Pt 1):763-8. Review. French.

PMID:
15536377
44.

Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.

Allain H, Ramelet AA, Polard E, Bentué-Ferrer D.

Drug Saf. 2004;27(9):649-60. Review.

PMID:
15230646
45.

Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?

Latour P, Biraben A, Polard E, Bentué-Ferrer D, Beauplet A, Tribut O, Allain H.

Hum Psychopharmacol. 2004 Apr;19(3):193-203.

PMID:
15079854
46.

[Myoclonic encephalopathy associated with proton pump inhibitors].

Boulliat J, Polard E, Colin F, Bentué-Ferrer D, Allain H.

Rev Neurol (Paris). 2004 Mar;160(3):350-1. French.

PMID:
15037850
47.

[Selective COX-2 inhibitor-associated colitis: two case reports].

d'Halluin PN, Turlin B, Polard E, Dinasquet M, Pagenault M, Rioux N, Gosselin M, Bretagne JF, Heresbach D.

Gastroenterol Clin Biol. 2003 Oct;27(10):932-5. Review. French.

48.

Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

Bentué-Ferrer D, Tribut O, Polard E, Allain H.

CNS Drugs. 2003;17(13):947-63. Review.

PMID:
14533945
49.

[Ludopathy induced by levodopa associated with bromocriptin].

Polard E, Trioux E, Flet L, Colin F, Allain H.

Presse Med. 2003 Aug 9;32(26):1223. French. No abstract available.

PMID:
14506463
50.

Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.

Allain H, Bentué-Ferrer D, Breton SL, Polard E, Gandon JM.

Hum Psychopharmacol. 2003 Jul;18(5):369-74.

PMID:
12858323

Supplemental Content

Loading ...
Support Center